Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.

Chataway, J; Schuerer, N; Alsanousi, A; Chan, D; MacManus, D; Hunter, K; Anderson, V; Bangham, CR; Clegg, S; Nielsen, C; +7 more... Fox, NC; Wilkie, D; Nicholas, JM; Calder, VL; Greenwood, J; Frost, C; Nicholas, R; (2014) Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet, 383 (9936). pp. 2213-21. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(13)62242-4

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(13)62242-4

Abstract

Share

Download

Filename: Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar